Deoxycytidine

"Deoxycytidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE.

Descriptor ID	D003841
MeSH Number(s)	D03.383.742.680.245.500 D13.570.230.329 D13.570.685.245.500
Concept/Terms	Deoxycytidine Deoxycytidine Cytosine Deoxyribonucleoside Deoxyribonucleoside, Cytosine Cytosine Deoxyriboside Deoxyriboside, Cytosine

Below are MeSH descriptors whose meaning is more general than "Deoxycytidine".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyrimidines [D03.383.742]
Pyrimidine Nucleosides [D03.383.742.680]
Cytidine [D03.383.742.680.245]
Deoxycytidine [D03.383.742.680.245.500]
Nucleic Acids, Nucleotides, and Nucleosides [D13]
Nucleosides [D13.570]
Deoxyribonucleosides [D13.570.230]
Deoxycytidine [D13.570.230.329]
Pyrimidine Nucleosides [D13.570.685]
Cytidine [D13.570.685.245]
Deoxycytidine [D13.570.685.245.500]

Below are MeSH descriptors whose meaning is related to "Deoxycytidine".

Below are MeSH descriptors whose meaning is more specific than "Deoxycytidine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Deoxycytidine" by people in this website by year, and whether "Deoxycytidine" was a major or minor topic of these publications.

Bar chart showing 20 publications over 13 distinct years, with a maximum of 4 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2005	1	1	2
2008	1	0	1
2009	0	1	1
2011	2	2	4
2012	0	2	2
2013	1	0	1
2014	2	0	2
2017	1	1	2
2018	1	0	1
2019	1	0	1
2023	0	1	1
2024	1	0	1

Below are the most recent publications written about "Deoxycytidine" by people in Profiles.

Umar S, Samokhvalov A. Encapsulation of Gemcitabine on Porphyrin Aluminum Metal-Organic Framework by Mechano-Chemistry, Delayed Drug Release and Cytotoxicity to Pancreatic Cancer PANC-1 Cells. Molecules. 2024 Jul 04; 29(13).

View in: PubMed
Inkoom A, Ndemazie NB, Smith T, Frimpong E, Bulusu R, Poku R, Zhu X, Han B, Trevino J, Agyare E. Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer. BMC Cancer. 2023 May 13; 23(1):435.

View in: PubMed
Parvathaneni S, Sharma S. The DNA repair helicase RECQ1 has a checkpoint-dependent role in mediating DNA damage responses induced by gemcitabine. J Biol Chem. 2019 10 18; 294(42):15330-15345.

View in: PubMed
Krulikas LJ, McDonald IM, Lee B, Okumu DO, East MP, Gilbert TSK, Herring LE, Golitz BT, Wells CI, Axtman AD, Zuercher WJ, Willson TM, Kireev D, Yeh JJ, Johnson GL, Baines AT, Graves LM. Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth. SLAS Discov. 2018 09; 23(8):850-861.

View in: PubMed
Affram K, Udofot O, Singh M, Krishnan S, Reams R, Rosenberg J, Agyare E. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging. PLoS One. 2017; 12(9):e0185116.

View in: PubMed
Youngren-Ortiz SR, Hill DB, Hoffmann PR, Morris KR, Barrett EG, Forest MG, Chougule MB. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer. J Aerosol Med Pulm Drug Deliv. 2017 Oct; 30(5):299-321.

View in: PubMed
Sviatenko LK, Gorb L, Hovorun D, Leszczynski J. In silico kinetics and mechanism of interaction of cis-2-butene-1,4-dial with 2'-deoxycytidine. Chem Res Toxicol. 2014 Jun 16; 27(6):981-9.

View in: PubMed
Gu J, Wang J, Leszczynski J. Electron interaction with phosphate cytidine oligomer dCpdC: base-centered radical anions and their electronic spectra. J Phys Chem B. 2014 Jan 30; 118(4):915-20.

View in: PubMed
Xu D, Cobb MG, Gavilano L, Witherspoon SM, Williams D, White CD, Taverna P, Bednarski BK, Kim HJ, Baldwin AS, Baines AT. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine. Cancer Biol Ther. 2013 Jun; 14(6):492-501.

View in: PubMed
McComsey GA, Daar ES, O'Riordan M, Collier AC, Kosmiski L, Santana JL, Fichtenbaum CJ, Fink H, Sax PE, Libutti DE, Gerschenson M. Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202. J Infect Dis. 2013 Feb 15; 207(4):604-11.

View in: PubMed

People

Explore

Similar Concepts

Top Journals